Akihiro Yasoda

4.9k total citations
114 papers, 3.6k citations indexed

About

Akihiro Yasoda is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Genetics. According to data from OpenAlex, Akihiro Yasoda has authored 114 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Molecular Biology, 28 papers in Endocrinology, Diabetes and Metabolism and 28 papers in Genetics. Recurrent topics in Akihiro Yasoda's work include Connective tissue disorders research (17 papers), Hormonal Regulation and Hypertension (14 papers) and Heart Failure Treatment and Management (13 papers). Akihiro Yasoda is often cited by papers focused on Connective tissue disorders research (17 papers), Hormonal Regulation and Hypertension (14 papers) and Heart Failure Treatment and Management (13 papers). Akihiro Yasoda collaborates with scholars based in Japan, United States and Canada. Akihiro Yasoda's co-authors include Kazuwa Nakao, Michio Suda, Yasato Komatsu, Naohisa Tamura, Yoshihiro Ogawa, Masako Miura, Hideki Chusho, Toshihito Fujii, Takashi Miyazawa and Kiyoshi Tanaka and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Akihiro Yasoda

110 papers receiving 3.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Akihiro Yasoda Japan 32 1.4k 777 746 710 585 114 3.6k
Noriyuki Namba Japan 28 2.8k 2.0× 757 1.0× 1.0k 1.4× 557 0.8× 593 1.0× 100 5.0k
Yosuke Okada Japan 38 2.0k 1.4× 638 0.8× 1.1k 1.5× 341 0.5× 1.1k 1.9× 235 5.0k
Yasato Komatsu Japan 31 1.6k 1.1× 537 0.7× 586 0.8× 2.0k 2.8× 732 1.3× 74 5.0k
Yukihiro Hasegawa Japan 31 2.1k 1.5× 1.5k 2.0× 579 0.8× 250 0.4× 1.3k 2.2× 258 5.0k
John L. Fowlkes United States 38 1.8k 1.3× 549 0.7× 724 1.0× 267 0.4× 1.5k 2.5× 89 4.1k
Yoshiki Seino Japan 39 1.9k 1.3× 1.4k 1.8× 751 1.0× 239 0.3× 1.3k 2.2× 238 6.0k
Masakatsu Sone Japan 32 1.4k 1.0× 173 0.2× 335 0.4× 539 0.8× 541 0.9× 100 3.2k
Dong‐Kyu Jin South Korea 33 917 0.7× 1.1k 1.4× 184 0.2× 591 0.8× 763 1.3× 261 3.9k
Paul R. Crisostomo United States 37 907 0.6× 288 0.4× 350 0.5× 583 0.8× 347 0.6× 92 3.7k
Michael Mannstadt United States 31 1.3k 0.9× 1.3k 1.7× 739 1.0× 158 0.2× 825 1.4× 99 5.3k

Countries citing papers authored by Akihiro Yasoda

Since Specialization
Citations

This map shows the geographic impact of Akihiro Yasoda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Akihiro Yasoda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Akihiro Yasoda more than expected).

Fields of papers citing papers by Akihiro Yasoda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Akihiro Yasoda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Akihiro Yasoda. The network helps show where Akihiro Yasoda may publish in the future.

Co-authorship network of co-authors of Akihiro Yasoda

This figure shows the co-authorship network connecting the top 25 collaborators of Akihiro Yasoda. A scholar is included among the top collaborators of Akihiro Yasoda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Akihiro Yasoda. Akihiro Yasoda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ueda, Yohei, Takafumi Yamashita, Ichiro Yamauchi, et al.. (2024). Neprilysin Inhibition Promotes Skeletal Growth via the CNP/NPR-B Pathway. Endocrinology. 165(7). 4 indexed citations
2.
Komiyama, Maki, Yuka Ozaki, Hajime Yamakage, et al.. (2023). Impact of smoking initiation age on nicotine dependency and cardiovascular risk factors: a retrospective cohort study in Japan. European Heart Journal Open. 4(1). oead135–oead135. 6 indexed citations
3.
Kitamura, Takuya, Yuki Ishihara, Toru Kusakabe, et al.. (2023). A case of osteogenesis imperfecta caused by a <i>COL1A1</i> variant, coexisting with pituitary stalk interruption syndrome. Endocrine Journal. 70(8). 839–846. 3 indexed citations
4.
5.
Yamauchi, Ichiro, Yukiko Okuno, Kentaro Okamoto, et al.. (2022). High-throughput Screening in Combination With a Cohort Study for Iodothyronine Deiodinases. Endocrinology. 163(8). 5 indexed citations
6.
7.
Komiyama, Maki, Yuka Ozaki, Yusuke Miyazaki, et al.. (2021). Neutrophil/lymphocyte ratio is correlated with levels of inflammatory markers and is significantly reduced by smoking cessation. Journal of International Medical Research. 49(6). 3619080151–3619080151. 11 indexed citations
8.
Yamauchi, Ichiro, Takafumi Yamashita, Tetsuya Tagami, et al.. (2021). Bezafibrate induces hypothyroidism in a patient with resistance to thyroid hormone β due to a G347R variant. Clinical Endocrinology. 96(2). 236–245. 2 indexed citations
9.
Kusakabe, Toru, Hiroshi Arai, Yuji Yamamoto, et al.. (2021). Phase angle from bioelectrical impedance analysis is a useful indicator of muscle quality. Journal of Cachexia Sarcopenia and Muscle. 13(1). 180–189. 132 indexed citations
10.
Umakoshi, Hironobu, Yuki Ishihara, Kazutaka Nanba, et al.. (2020). Reassessment of Urinary Aldosterone Measurement After Saline Infusion in Primary Aldosteronism. Journal of the Endocrine Society. 4(9). bvaa100–bvaa100. 3 indexed citations
11.
Yamauchi, Ichiro, Akihiro Yasoda, Shigemi Matsumoto, et al.. (2019). Incidence, features, and prognosis of immune-related adverse events involving the thyroid gland induced by nivolumab. PLoS ONE. 14(5). e0216954–e0216954. 105 indexed citations
12.
Umakoshi, Hironobu, Yuki Ishihara, Kazutaka Nanba, et al.. (2019). Seated saline infusion test in predicting subtype diagnosis of primary aldosteronism. Clinical Endocrinology. 91(6). 737–742. 12 indexed citations
13.
Furuya, Mayumi, Toshihito Fujii, Keisho Hirota, et al.. (2019). Foramen magnum stenosis and midface hypoplasia in C-type natriuretic peptide-deficient rats and restoration by the administration of human C-type natriuretic peptide with 53 amino acids. PLoS ONE. 14(5). e0216340–e0216340. 5 indexed citations
14.
Miyazaki, Takahiro, Kentaro Otani, Ayano Chiba, et al.. (2018). A New Secretory Peptide of Natriuretic Peptide Family, Osteocrin, Suppresses the Progression of Congestive Heart Failure After Myocardial Infarction. Circulation Research. 122(5). 742–751. 39 indexed citations
15.
Yamanaka, S., Kazumasa Nakao, Noriaki Koyama, et al.. (2017). Circulatory CNP Rescues Craniofacial Hypoplasia in Achondroplasia. Journal of Dental Research. 96(13). 1526–1534. 15 indexed citations
16.
Yamauchi, Ichiro, Toshihito Fujii, Daisuke Taura, et al.. (2017). Clinical Features of Nivolumab-Induced Thyroiditis: A Case Series Study. Thyroid. 27(7). 894–901. 118 indexed citations
17.
Koyama, Noriaki, Masako Miura, Kazumasa Nakao, et al.. (2012). Human Induced Pluripotent Stem Cells Differentiated into Chondrogenic Lineage Via Generation of Mesenchymal Progenitor Cells. Stem Cells and Development. 22(1). 102–113. 72 indexed citations
18.
Yasoda, Akihiro & Kazuwa Nakao. (2010). [Genetic basis for skeletal disease. CNP therapy for achondroplasia].. PubMed. 20(8). 1212–8. 2 indexed citations
19.
Yasoda, Akihiro, Yasato Komatsu, Kazuwa Nakao, & Yoshihiro Ogawa. (2004). [C-type natriuretic peptide(CNP)--a novel stimulator of bone growth formed through endochondral ossification].. PubMed. 62 Suppl 2. 77–81. 2 indexed citations
20.
Komatsu, Yasato, Akihiro Yasoda, Hideki Chusho, & Kazuwa Nakao. (2003). [The possible novel treatment of achondroplasia, C-type natriuretic peptide (CNP)].. PubMed. 13(12). 1578–81. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Noriyuki Namba Breakdown of academic impact, for papers by Yosuke Okada Breakdown of academic impact, for papers by Yasato Komatsu Breakdown of academic impact, for papers by Yukihiro Hasegawa Breakdown of academic impact, for papers by John L. Fowlkes Breakdown of academic impact, for papers by Yoshiki Seino Breakdown of academic impact, for papers by Masakatsu Sone Breakdown of academic impact, for papers by Dong‐Kyu Jin Breakdown of academic impact, for papers by Paul R. Crisostomo Breakdown of academic impact, for papers by Michael Mannstadt
Rankless by CCL
2026